Your browser doesn't support javascript.
loading
MicroRNA Expression Profiling-Potential Molecular Discrimination of Papillary Thyroid Carcinoma Subtypes.
Silaghi, Horatiu; Pop, Laura Ancuța; Georgescu, Carmen Emanuela; Muntean, Diana; Crișan, Doinița; Silaghi, Patricia; Lungu, Ionela; Nasui, Bogdana Adriana; Dulf, Eva-H; Braicu, Cornelia; Berindan-Neagoe, Ioana; Silaghi, Cristina Alina.
Afiliação
  • Silaghi H; Department of Surgery V, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
  • Pop LA; Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
  • Georgescu CE; Department of Endocrinology, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
  • Muntean D; Department of Pathology, Clinic Municipal Hospital Cluj-Napoca, Tabacarilor Street 11, 400139 Cluj-Napoca, Romania.
  • Crișan D; Department of Pathology, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
  • Silaghi P; Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
  • Lungu I; Cardiomed Medical Center, 17 Republicii Street, 400015 Cluj-Napoca, Romania.
  • Nasui BA; Department of Community Health, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
  • Dulf EH; Department of Automation, Faculty of Automation and Computer Science, Technical University of Cluj-Napoca, 28 Memorandumului Street, 400014 Cluj-Napoca, Romania.
  • Braicu C; Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
  • Berindan-Neagoe I; Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 400337 Cluj-Napoca, Romania.
  • Silaghi CA; Department of Endocrinology, "Iuliu Hatieganu" University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.
Biomedicines ; 12(1)2024 Jan 09.
Article em En | MEDLINE | ID: mdl-38255241
ABSTRACT
Recent research has revealed the importance of miRNAs in the diagnosis and clinical evolution of papillary thyroid cancer (PTC). We aim to identify a specific miRNA profile that could differentiate between specific subtypes of PTC.

METHODS:

In this cross-sectional study, total RNA was extracted from paraffin-embedded tissues of 43 patients, 17 with an infiltrative follicular variant of PTC (iFVPTC) and 26 with a conventional variant of PTC (cPTC). Nine miRNAs were evaluated using qRT-PCR technology and specific miRNA assays.

RESULTS:

We found specific patterns for cPTC and iFVPTC, such as miRNA altered in both types of tumours (miR-146b-5p, miR-181a-5p, miR-221-3p, miR-21-5p and miR-222-3p) and two miRNAs significantly expressed only in cPTC (miR-20b-5p, miR-21-5p). The iFVPTC group presented strong and moderate correlations between miRNA expression and clinical data. miR-221-3p, miR-195-5p, miR-181-5p, miR-146b-5p and miR-222 were correlated with age, tumour size (TS) or lymph node metastases (N), while only miR-20b-5p, miR-195-5p and miR-181-5p were correlated with TS, N and age in the cPTC group.

CONCLUSIONS:

The present study allowed the identification of a signature of two miRNAs to confirm miRNA differences between the two histological subtypes of TC. Our results provide advances in the molecular diagnosis of TC and could help to improve the diagnostic performance of already existing molecular classifiers.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article